Introduction
============

Perfluorinated chemicals (PFCs) are humanmade chemicals that have been widely used in different types of industry for the past 60 years. They are ubiquitous and widely detected in the environment, wildlife, and humans. The main pathway of exposure to PFCs in the general population is through the oral route, including digestion of contaminated food and water ([@r5]; [@r8]). Perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) are the most abundant and commonly detected PFCs in biota and humans. PFOS was added to Annex B of the Stockholm Convention on Persistent Organic Pollutants (POPs) in 2009 ([@r46]). Although PFOS and PFOA are being voluntarily phased out by several industries, they are persistent and still present in older products. PFCs are resistant to metabolism and have long elimination half-lives; serum elimination of PFOS and PFOA in human sera is estimated to take 5.4 and 3.8 years, respectively ([@r35]). This results in the bioaccumulation of PFCs in the human body.

Recent research has shown that PFCs perturb metabolic end points, including lipid synthesis, glucose metabolism, and thyroid hormone balance in animals ([@r39]; [@r44]). In addition, PFCs have been shown to decrease testosterone and increased estradiol levels in the serum of mice ([@r25]; [@r28]; [@r49]). Some reports have found that PFCs can increase corticosterone in rodents ([@r2]; [@r59]). In contrast, other studies have found that PFCs reduce cortisol and corticosterone levels in salmon and human cells ([@r27]; [@r31]).

Increased steroid hormone production during pregnancy is essential to meet both the maternal demand for increased estrogens and cortisol production and the fetal demand for reproductive and physical growth and development. In contrast, excess cortisol may also be harmful to the fetus. Pregnancy is a transient physiologic period of hypercortisolism during which cortisol levels increase to two to three times their normal levels. However, the fetus is protected against this cortisol rise, because 11β-hydroxysteroid dehydrogenase 2 (11β-HSD2) in the placenta inactivates cortisol into cortisone. The human fetal adrenal gland is enormous relative to that of the adult organ, and adrenal steroid synthesis is increased in the fetus. The major steroid produced by the fetal adrenal gland is sulfoconjugated dehydroepiandrosterone (DHEAS) and DHEA, which are the main precursors of sex hormones and cortisol antagonists ([@r30]).

A fetus is exposed to PFCs because of maternal--fetal passage during organ development ([@r13]). Some epidemiological studies in the general population suggest that these compounds are associated with poor birth outcomes such as reduced birth size ([@r6]; [@r17]; [@r50]). Cholesterol is a substrate of all steroid hormones. Previous human studies have reported that PFCs may change the cholesterol profile in pregnant ([@r40]) and nonpregnant women ([@r7]; [@r51]). [@r16] reported an inverse association between PFOS and testosterone levels in serum samples of adult men. Previously, our group has reported a negative association between prenatal PFOS and progesterone hormone levels of cord blood samples in male and female infants. In addition, PFOS was negatively associated with testosterone/estradiol in male infants, whereas prenatal PFOA exposure was positively associated with progesterone levels in cord blood samples of both sexes ([@r15]). However, the effects of PFCs on glucocorticoid hormones and androgenic hormones (the main substrates of testosterone and estrogen) are not well understood in humans.

We investigated whether prenatal exposure to PFOS and PFOA was associated with cortisol and cortisone levels in cord blood samples in a birth cohort using a prospective design. In addition to glucocorticoids, to gain a better understanding of the effects of PFCs on steroidogenesis, we examined the association of PFCs with DHEA and androstenedione as androgenic hormones in cord blood and assessed the balance of glucocorticoids and androgenic hormones in infants.

Methods
=======

Study Population
----------------

This study was part of the Hokkaido Study on the Environment and Children's Health conducted between July 2002 and October 2005. The details of this study have been described previously ([@r22], [@r20]). In this prospective birth cohort, pregnant women between 23 and 35 weeks of gestation were recruited and gave birth at one hospital in Sapporo, Japan. All participants were native Japanese and residents of Sapporo city or the surrounding areas. Of the 1,796 potentially eligible women, the following subjects were excluded: women who decided to participate in the Japanese cord blood bank (22% of those approached) and women who decided to deliver at another hospital (3% of those approached). Ultimately, 514 (28.6%) pregnant women agreed to participate in this study. Of the 514 mother--infant pairs, 10 were excluded due to miscarriage, stillbirth, relocation, or voluntary withdrawal from the study before follow-up.

Questionnaires and Medical Records
----------------------------------

A self-administered questionnaire survey was completed after the second trimester of pregnancy that contained information related to previous medical history, smoking, socioeconomic status, alcohol, and caffeine intake during pregnancy, and food intake frequency during pregnancy including daily fish intake ([@r50]). A self-administered questionnaire described by [@r32] was used to estimate alcohol and caffeine intake during pregnancy. Medical information, including maternal age, maternal body mass index (BMI) before pregnancy, parity, gestational age, pregnancy complications, type of delivery, infant's sex, and birth size, was obtained from participant medical records. All participants provided written informed consent and the study protocol was approved by the institutional ethical board for epidemiological studies at the Graduate School of Medicine and the Center for Environmental and Health Sciences, Hokkaido University.

Blood Sampling and Exposure Assessment
--------------------------------------

A 40-mL blood sample was taken from the maternal peripheral vein after the second trimester of pregnancy to measure PFOS and PFOA levels. All samples were stored at --80°C until analysis. Detailed methods of the measurement of PFOS and PFOA have been described in our previous report ([@r10]; [@r33]). In brief, serum samples (0.1 mL) were mixed with 0.2 mL internal standard (^13^C~4~-PFOS-Na^+^ and ^13^C~2~-PFOA) solution containing acetonitrile. After centrifugation, the supernatant was transferred to a polypropylene tube. An aliquot of the filtered sample solution was subjected to column-switching liquid chromatography--tandem mass spectrometry (LC-MS/MS). The detection limit for both PFOS and PFOA was 0.5 ng/mL. The PFOS levels were detected in all samples, and for samples with PFOA levels below the detection limit, we used a value of half the detection limit (0.25 ng/mL).

Outcome Assessment
------------------

Cord blood samples (10--30 mL) were collected from the umbilical vein at delivery and stored at --80°C until analysis. Concentrations of cortisol, cortisone, DHEA, and androstenedione were measured in cord blood samples using LC-MS/MS ([@r53], [@r54]) at Aska Phrama Medical Co., Ltd (Kanagawa, Japan). The detection limits for cortisol and cortisone were 0.250 and 0.100 ng/mL, respectively. The detection limit for DHEA and androstenedione was 0.010 ng/mL.

Data Analysis
-------------

The following subjects were excluded from the analysis of associations between maternal PFCs and glucocorticoids: women with pregnancy-induced hypertension (*n* = 11), women with diabetes mellitus (*n* = 1), mother--infant pairs with fetal heart failure (*n* = 1), and twins (*n* = 7). After exclusion of these subjects, data on PFOS and PFOA concentrations in 429 mother--infant pairs were available. Of those, data on maternal blood during pregnancy and infant cord blood samples in 185 pairs were available and included in the data analysis. Because of the skewed distributions, we treated levels of PFCs and glucocorticoid and androgenic hormones as a continuous variable on a log~10~ scale.

We analyzed correlations between PFOS and PFOA concentrations and the characteristics of the mothers and infants using the Spearman correlation test, the Mann--Whitney *U*-test, and Kruskal--Wallis test. The same statistical analyses were performed to find associations between steroid hormone levels and participants' characteristics. We performed multiple-regression analysis to examine the association between glucocorticoid and androgenic hormones and the levels of PFCs in maternal serum samples. Potential confounders were selected according to how the covariates in this paper were associated with PFC exposure levels (smoking and caffeine intake during pregnancy, blood sampling period), hormone levels or both (parity) as shown in [Tables 1](#t1){ref-type="table"} and [2](#t2){ref-type="table"} (*p* \< 0.1). Because of the association of fetal serum steroid hormone levels in humans to gestational age ([@r38]), we also considered this as a confounder. In addition, we included maternal educational levels as an indicator of socioeconomic status into the fully adjusted models. To assess a dose--response relationship, we divided PFC levels into four quartiles, and least square means (LSMs) and 95% confidence intervals (CI) were calculated. To calculate a value for the trend, we assigned the median concentration to all persons for each corresponding quartile. We compared the least square means of the steroid hormones for each quartile using the Hsu--Dunnet method to accommodate for multiple comparisons. We performed all of the statistical analyses using JMP clinical 5 (SAS Institute Inc., Cary, NC, USA), and results were considered significant when \< 0.05.

###### 

Maternal blood PFOS and PFOA levels (ng/mL) in relation to the characteristics of subjects participating in the Hokkaido Study on Environment and Children's Health, Sapporo, Japan, 2002--2005 (*n* = 185).

  Characteristics                                                                                                                                                       *n*   PFOS \[mean ± SD, median (25--75 percentile), or correlation\]^*a*^   *p*-Value   PFOA \[mean ± SD, median (25--75 percentile), or correlation\]^*a*^   *p*-Value
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----- --------------------------------------------------------------------- ----------- --------------------------------------------------------------------- -----------
  Mean ± SD                                                                                                                                                             185   5.78 ± 2.7                                                                        1.60 (0.96)                                                           
  Median (minimum, maximum)                                                                                                                                             185   5.20 (1.50, 16.20)                                                                1.40 (\< LOD, 5.30)                                                   
  Maternal characteristics                                                                                                                                                                                                                                                                                                            
  Age (years)^*a*^                                                                                                                                                      185   ρ = --0.047                                                           0.525       ρ = --0.048                                                           0.512
  Prepregnancy BMI (kg/m^2^)^*a*^                                                                                                                                       185   ρ = --0.027                                                           0.712       ρ = --0.031                                                           0.671
  Parity^*b*^                                                                                                                                                                                                                                                                                                                         
  0                                                                                                                                                                     99    6.37 ± 0.27                                                           0.001       1.94 ± 0.08                                                           \< 0.001
  ≥1                                                                                                                                                                    86    5.09 ± 0.29                                                                       1.21 ± 0.09                                                           
  Educational level (years)^*b*^                                                                                                                                                                                                                                                                                                      
  ≤ 12                                                                                                                                                                  86    5.59 ± 0.30                                                           0.392       1.53 ± 0.10                                                           0.350
  ≥ 13                                                                                                                                                                  99    5.94 ± 0.27                                                                       1.66 ± 0.09                                                           
  Annual household income (million yen)^*b*,*c*^                                                                                                                                                                                                                                                                                      
  \< 5                                                                                                                                                                  129   5.64 ± 0.24                                                           0.374       1.63 ± 0.08                                                           0.606
  ≥ 5                                                                                                                                                                   54    6.04 ± 0.37                                                                       1.55 ± 0.13                                                           
  Smoking during pregnancy^*b*^                                                                                                                                                                                                                                                                                                       
  Yes                                                                                                                                                                   33    4.73 ± 0.47                                                           0.015       1.27 ± 0.16                                                           0.027
  No                                                                                                                                                                    152   6.01 ± 0.22                                                                       1.67 ± 0.07                                                           
  Alcohol intake during pregnancy^*b*^                                                                                                                                                                                                                                                                                                
  Yes                                                                                                                                                                   60    5.61 ± 0.35                                                           0.324       1.61 ± 0.12                                                           0.904
  No                                                                                                                                                                    125   5.86 ± 0.24                                                                       1.60 ± 0.08                                                           
  Caffeine intake during pregnancy (mg/day)^*a*^                                                                                                                              ρ = --0.083                                                           0.257       ρ = --0.193                                                           0.008
  Fish intake during pregnancy^*b*^                                                                                                                                                                                                                                                                                                   
  Inshore fish                                                                                                                                                                                                                                                                                                                        
  ≤ 1--2 times/month                                                                                                                                                    96    5.70 ± 0.28                                                           0.684       1.63 ± 0.09                                                           0.632
  ≥ 1--2 times/week                                                                                                                                                     89    5.86 ± 0.29                                                                       1.57 ± 0.10                                                           
  Deep sea fish                                                                                                                                                                                                                                                                                                                       
  ≤ 1--2 times/month                                                                                                                                                    83    5.60 ± 0.30                                                           0.435       1.59 ± 0.10                                                           0.877
  ≥ 1--2 times/week                                                                                                                                                     102   5.92 ± 0.27                                                                       1.61 ± 0.09                                                           
  Blood sampling period^*d*^                                                                                                                                                                                                                                                                                                          
  23--31 weeks                                                                                                                                                          74    6.38 ± 0.30                                                           \< 0.001    1.77 ± 0.11                                                           0.086
  32--34 weeks                                                                                                                                                          43    6.44 ± 0.40                                                                       1.61 ± 0.14                                                           
  35--41 weeks                                                                                                                                                          68    4.70 ± 0.32                                                                       1.41 ± 0.11                                                           
  Gestational age (days)^*a*^                                                                                                                                                 ρ = 0.028                                                             0.702       ρ = 0.062                                                             0.399
  Infant characteristics                                                                                                                                                                                                                                                                                                              
  Sex^*b*^                                                                                                                                                                                                                                                                                                                            
  Male                                                                                                                                                                  81    6.16 ± 0.30                                                           0.100       1.73 ± 0.10                                                           0.117
  Female                                                                                                                                                                104   5.48 ± 0.27                                                                       1.50 ± 0.09                                                           
  Birth weight^*a*^                                                                                                                                                     251   ρ = --0.108                                                           0.140       ρ = --0.162                                                           0.026
  ^***a***^Spearman's correlation test (ρ). ^***b***^Mann--Whitney *U*-test. ^***c***^Missing data: annual household income (*n* = 2). ^***d***^Kruskal--Wallis test.                                                                                                                                                                 

###### 

Cord blood glucocorticoid levels (ng/mL) in relation to characteristics of the subjects participating in the Hokkaido Study on Environment and Children's Health, Sapporo, Japan, 2002--2005 (*n* = 185).

  Characteristics                                                                                                                      *n*   Cortisol \[mean ± SD or correlation\]^*a*^   *p*-Value   Cortisone \[mean ± SD or correlation\]^*a*^   *p*-Value   DHEA \[mean ± SD or correlation\]^*a*^   *p*-Value   Androstenedione \[mean ± SD or correlation\]^*a*^   *p*-Value
  ------------------------------------------------------------------------------------------------------------------------------------ ----- -------------------------------------------- ----------- --------------------------------------------- ----------- ---------------------------------------- ----------- --------------------------------------------------- -----------
  Maternal characteristics                                                                                                                                                                                                                                                                                                                                               
  Age (years)^*a*^                                                                                                                     185   ρ = --0.136                                  0.063       ρ = --0.134                                   0.068       ρ = --0.053                              0.466       ρ = 0.009                                           0.894
  Prepregnancy BMI (kg/m^2^)^*a*^                                                                                                      185   ρ = 0.044                                    0.546       ρ = 0.030                                     0.678       ρ = 0.036                                0.626       ρ = 0.020                                           0.782
  Parity^*b*^                                                                                                                                                                                                                                                                                                                                                            
  0                                                                                                                                    99    61.2 ± 3.5                                   \< 0.001    108.8 ± 4.1                                   \< 0.001    5.4 ± 1.0                                0.266       0.59 ± 0.08                                         0.477
  ≥ 1                                                                                                                                  86    33.4 ± 3.7                                               82.2 ± 4.4                                                3.7 ± 1.1                                            0.68 ± 0.09                                         
  Educational level (years)^*b*^                                                                                                                                                                                                                                                                                                                                         
  ≤ 12                                                                                                                                 86    48.6 ± 4.0                                   0.915       94.0 ± 4.6                                    0.519       5.2 ± 1.1                                0.452       0.63 ± 0.09                                         0.908
  ≥ 13                                                                                                                                 99    48.0 ± 3.7                                               98.2 ± 4.3                                                4.1 ± 1.0                                            0.64 ± 0.08                                         
  Annual household income (million yen)^*b*,*c*^                                                                                                                                                                                                                                                                                                                         
  \< 5                                                                                                                                 129   49.9 ± 3.3                                   0.499       98.0 ± 3.7                                    0.554       4.2 ± 0.87                               0.612       0.62 ± 0.07                                         0.101
  ≥ 5                                                                                                                                  54    45.8 ± 5.1                                               93.8 ± 5.8                                                5.0 ± 1.3                                            0.67 ± 0.11                                         
  Smoking during pregnancy^*b*^                                                                                                                                                                                                                                                                                                                                          
  Yes                                                                                                                                  33    40.9 ± 6.5                                   0.901       95.0 ± 7.5                                    0.852       3.8 ± 1.7                                0.623       0.50 ± 0.14                                         0.318
  No                                                                                                                                   152   48.1 ± 3.0                                               96.5 ± 3.5                                                4.8 ± 0.8                                            0.66 ± 0.06                                         
  Alcohol intake during pregnancy^*b*^                                                                                                                                                                                                                                                                                                                                   
  Yes                                                                                                                                  60    42.8 ± 4.8                                   0.169       95.0 ± 5.6                                    0.789       4.0 ± 1.3                                0.312       0.70 ± 0.10                                         0.47
  No                                                                                                                                   125   50.9 ± 3.3                                               96.8 ± 3.8                                                4.9 ± 0.9                                            0.60 ± 0.07                                         
  Caffeine intake during pregnancy (mg/day)^*a*^                                                                                             ρ = --0.004                                  0.953       ρ = --0.077                                   0.292       ρ = --0.003                              0.966       ρ = --0.063                                         0.392
  Fish intake during pregnancy^*b*^                                                                                                                                                                                                                                                                                                                                      
  Inshore fish                                                                                                                                                                                                                                                                                                                                                           
  ≤ 1--2 times/month                                                                                                                   96    46.7 ± 3.8                                   0.545       95.0 ± 4.4                                    0.68        3.8 ± 1.0                                0.280       0.65 ± 0.08                                         0.732
  ≥ 1--2 times/week                                                                                                                    89    50.0 ± 3.9                                               97.6 ± 4.6                                                5.5 ± 1.0                                            0.61 ± 0.08                                         
  Deep sea fish                                                                                                                                                                                                                                                                                                                                                          
  ≤ 1--2 times/month                                                                                                                   83    43.5 ± 4.1                                   0.122       97.0 ± 4.7                                    0.836       4.0 ± 1.1                                0.489       0.62 ± 0.09                                         0.850
  ≥ 1--2 times/week                                                                                                                    102   52.1 ± 3.7                                               95.6 ± 4.3                                                5.1 ± 1.0                                            0.64 ± 0.08                                         
  Gestational age (days)^*a*^                                                                                                          185   ρ = 0.105                                    0.153       ρ = 0.037                                     0.611       ρ = 0.009                                0.900       ρ = --0.037                                         0.608
  Infant characteristics                                                                                                                                                                                                                                                                                                                                                 
  Sex^*b*^                                                                                                                                                                                                                                                                                                                                                               
  Male                                                                                                                                 81    44.1 ± 4.1                                   0.18        97.9 ± 4.8                                    0.637       3.1 ± 1.1                                0.085       0.62 ± 0.09                                         0.799
  Female                                                                                                                               104   51.5 ± 3.6                                               94.9 ± 4.2                                                5.8 ± 1.0                                            0.65 ± 0.08                                         
  Birth weight^*a*^                                                                                                                    185   ρ = 0.001                                    0.983       ρ = 0.087                                     0.235       ρ = --0.052                              0.476       ρ = 0.048                                           0.515
  ^***a***^Spearman's correlation test (ρ). ^***b***^Mann--Whitney U-test. ^***c***^Missing data: annual household income (*n* = 2).                                                                                                                                                                                                                                     

Results
=======

In total, 185 mother--infant pairs were included in this study. The average (± SD) age of the mothers at birth was 29.7 ± 4.7 years; 53.5% of mothers were nulliparous ([Table 3](#t3){ref-type="table"}). Among pregnant women, 17.8% smoked and 32.4% consumed alcohol during pregnancy. Mean (± SD) birth weight was 3130.4 ± 331.6 g, and 43.8% of newborns were boys. PFOS levels were detected in all of the samples; however, PFOA levels were not detected in 11 maternal serum samples (5.9% of participants). The median (minimum, maximum) values of PFOS and PFOA were 5.20 ng/mL (1.50, 16.20 ng/mL) and 1.40 ng/mL (\< limit of detection, 5.30 ng/mL), respectively ([Table 1](#t1){ref-type="table"}). PFOS and PFOA concentrations were modestly correlated (Spearman's rho = 0.270, *p* \< 0.001). We observed statistically significant differences in mean PFOS concentrations by parity, smoking during pregnancy, and blood sampling period. Additionally, there were significant differences in mean PFOA concentrations by parity and smoking and caffeine intake during pregnancy.

###### 

Characteristics of subjects participating in the Hokkaido Study on Environment and Children's Health, Sapporo, Japan, 2002--2005 (*n* = 185).

  Characteristics                                             *n* (%) or mean ± SD
  ----------------------------------------------------------- ----------------------
  Maternal characteristics                                    
  Age (years)                                                 29.7 ± 4.7
  Prepregnancy BMI (kg/m^2^)                                  21.0 ± 2.9
  Parity                                                      
  0                                                           99 (53.5)
  ≥1                                                          86 (46.5)
  Educational level (years)                                   
  *≤12*                                                       86 (46.5)
  *≥13*                                                       99 (53.5)
  Annual household income (million yen)^*a*^                  
  \< 5                                                        129 (70.5)
  ≥ 5                                                         54 (29.5)
  Smoking during pregnancy                                    
  Yes                                                         33 (17.8)
  No                                                          152 (82.2)
  Alcohol intake during pregnancy                             
  Yes                                                         60 (32.4)
  No                                                          125 (67.6)
  Caffeine intake during pregnancy (mg/day)                   143.4 ± 126.2
  Blood sampling period                                       
  23--31 weeks                                                74 (40)
  32--34 weeks                                                43 (23.2)
  35--41 weeks                                                68 (36.8)
  Gestational age (days)                                      278.9 ± 6.7
  Infant characteristics                                      
  Sex                                                         
  Male                                                        81 (43.8)
  Female                                                      104 (56.2)
  Birth weight                                                3130.4 ± 331.6
  Birth length                                                48.4 ± 1.9
  ^***a***^Missing data: annual household income (*n* = 2).   

Median (25th--75th percentile) values of cortisol, cortisone, DHEA, and androstenedione in cord blood samples were 39.0 (22.5--65.6), 96.7 (69.1--124.4), 2.3 (1.8--3.1), and 0.45 (0.36--0.58) ng/mL, respectively ([Table 4](#t4){ref-type="table"}). The detection rate of these steroid hormones in cord blood samples was 100%. We found a strong positive correlation between cortisol and cortisone as well as DHEA and androstenedione levels. Furthermore, glucocorticoids showed a negative correlation with DHEA levels (see Table S1).

###### 

Concentrations (ng/mL) of steroid hormones in cord blood samples (*n* = 185).

  Hormone           *n*   Mean ± SD     Median (25th--75th)   \> LOD (%)
  ----------------- ----- ------------- --------------------- ------------
  Cortisol                                                    
  Total             185   48.3 ± 37.6   9.0 (22.5--65.6)      100
  Male              81    44.1 ± 30.6   38.2 (21.1--59.6)     100
  Female            104   51.5 ± 42.0   39.7 (24.4--67.0)     100
  Cortisone                                                   
  Total             185   96.2 ± 43.3   96.7 (69.1--124.4)    100
  Male              81    97.9 ± 38.7   97.2 (72.4--126.0)    100
  Female            104   94.9 ± 46.8   95.2 (66.3--124.5)    100
  DHEA                                                        
  Total             185   4.6 ± 10.2    2.3 (1.8--3.1)        100
  Male              81    3.1 ± 4.2     2.1 (1.6--2.7)        100
  Female            104   5.8 ± 13.1    2.6 (1.9--3.4)        100
  Androstenedione                                             
  Total             185   0.63 ± 0.84   0.45 (0.36--0.58)     100
  Male              81    0.62 ± 0.72   0.47 (0.36--0.60)     100
  Female            104   0.65 ± 0.93   0.44 (0.35--0.57)     100

The relationships between the cord blood levels of steroids and maternal and infant characteristics are shown in [Table 2](#t2){ref-type="table"}. Cortisol and cortisone levels in cord blood showed a negative association with maternal age (*p* \< 0.07). Glucocorticoid levels in cord blood of infants with multiparous mothers were significantly lower compared with those in infants with nulliparous mothers (*p* \< 0.001). Gestational age had a nonsignificant positive correlation with cortisol levels. DHEA and androstenedione levels did not show any significant association with maternal or infant characteristics.

As shown in [Table 5](#t5){ref-type="table"}, after controlling for potential confounders, prenatal PFOS concentration was inversely associated with cortisol levels (β = --0.844; 95% CI: --1.31, --0.378; *p* \< 0.001). Similarly, we observed a significant negative association between PFOS and cortisone levels (β = --1.15; 95% CI: --1.79, --0.515; *p* \< 0.001). In addition, prenatal PFOS concentrations were positively associated with DHEA levels (β = 0.365; 95% CI: 0.112, 0.618; *p* = 0.004). We found a nonsignificant positive association between PFOA and cortisol (β = 0.244; 95% CI: --0.119, 0.607; *p* = 0.186) and cortisone levels (β = 0.390; 95% CI: --0.108, 0.889; *p* = 0.124). Prenatal exposure to PFOA was negatively associated with DHEA levels (β = --0.250; 95% CI: --0.442, --0.058; *p* = 0.010). In addition, we assessed the association of PFCs with the ratios of cortisol to cortisone, cortisol to DHEA, and glucocorticoid to androgenic hormones. PFOS was negatively associated with the ratios of cortisol/DHEA and glucocorticoid/androgenic hormones but positively associated with cortisol/cortisone ratio. In contrast, PFOA showed a positive nonsignificant association with cortisol to DHEA ratio, and the glucocorticoid to androgenic hormones ratios. For further examination, the association of PFCs with glucocorticoids and androgenic hormones was stratified by sex to identify any sex differences. However, we did not find any specific differences by sex, just that the association of PFCs and DHEA was stronger among boys than among girls (see Tables S2 and S3).

###### 

Association of prenatal PFC levels with cord blood glucocorticoids and androgenic hormones (*n* = 185).

  Hormone                                                                                                                                                                                                                                PFOS                        PFOA                                    
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------- ---------- ---------------------------- -------
  Cortisol                                                                                                                                                                                                                                                                                                   
  Crude                                                                                                                                                                                                                                  --0.774 (--1.19, --0.356)   \< 0.001   0.231 (--0.083, 0.546)       0.149
  Adjusted^*a*^                                                                                                                                                                                                                          --0.844 (--1.31, --0.378)   \< 0.001   0.244 (--0.119, 0.607)       0.186
  Cortisone                                                                                                                                                                                                                                                                                                  
  Crude                                                                                                                                                                                                                                  --1.11 (--1.68, --0.555)    \< 0.001   0.222 (--0.205, 0.650)       0.306
  Adjusted^*a*^                                                                                                                                                                                                                          --1.15 (--1.79, --0.515)    \< 0.001   0.390 (--0.108, 0.889)       0.124
  DHEA                                                                                                                                                                                                                                                                                                       
  Crude                                                                                                                                                                                                                                  0.342 (0.120, 0.564)        0.002      --0.155 (--0.320, 0.009)     0.064
  Adjusted^*a*^                                                                                                                                                                                                                          0.365 (0.112, 0.618)        0.004      --0.250 (--0.442, --0.058)   0.010
  Androstenedione                                                                                                                                                                                                                                                                                            
  Crude                                                                                                                                                                                                                                  --0.038 (--0.212, 0.134)    0.657      --0.099 (--0.225, 0.026)     0.119
  Adjusted^*a*^                                                                                                                                                                                                                          --0.013 (--0.208, 0.181)    0.893      --0.105 (--0.251, 0.041)     0.157
  Cortisol/cortisone                                                                                                                                                                                                                                                                                         
  Crude                                                                                                                                                                                                                                  0.344 (0.086, 0.602)        0.009      0.008 (--0.183, 0.200)       0.928
  Adjusted^*a*^                                                                                                                                                                                                                          0.312 (0.025, 0.599)        0.032      --0.146 (--0.364, 0.072)     0.188
  Cortisol/DHEA ratio                                                                                                                                                                                                                                                                                        
  Crude                                                                                                                                                                                                                                  --1.11 (--1.71, --0.516)    \< 0.001   0.386 (--0.064, 0.838)       0.092
  Adjusted^*a*^                                                                                                                                                                                                                          --1.21 (--1.88, --0.531)    \< 0.001   0.494 (--0.030, 1.02)        0.064
  Glucocorticoid/androgenic hormones ratio                                                                                                                                                                                                                                                                   
  Crude                                                                                                                                                                                                                                  --1.24 (--1.89, --0.608)    \< 0.001   0.368 (--0.115, 0.852)       0.134
  Adjusted^*a*^                                                                                                                                                                                                                          --1.33 (--2.05, --0.601)    \< 0.001   0.551 (--0.013, 1.11)        0.057
  Both exposure and outcome measures were log~10~ transformed. ^***a***^Fully adjusted for gestational age, maternal age, parity, smoking and caffeine intake during pregnancy, maternal educational level, and blood sampling period.                                                                       

We also divided maternal PFC levels into quartiles and examined the dose--response relationship between PFCs and steroid hormones ([Figure 1](#f1){ref-type="fig"}; see also Table S4). The quartile analysis after full adjustment showed that the highest quartile of PFOS was associated with a --23.98 ng/mL (95% CI: --47.12, --11.99; *p* for trend = 0.006) in cortisol and --63.21 ng/mL (95% CI: --132.56, --26.72; *p* for trend \< 0.001) in cortisone levels compared with the lowest quartile. PFOA showed a positive trend for glucocorticoid levels but was not statistically significant. In addition, we found significant increases in DHEA levels across PFOS quartiles (quartile 4 vs. 1 difference: 1.33 ng/mL; 95% CI: 0.17, 1.82; *p* for trend = 0.017), but significant decreases in DHEA levels among PFOA quartiles (quartile 4 vs. 1 difference = --1.23 ng/mL; 95% CI: --1.72, --0.25; *p* for trend = 0.004). We did not observe a dose--response relationship between PFCs and androstenedione levels.

![The dose--response relationship of prenatal PFOS (*A*) and PFOA (*B*) quartiles with glucocorticoid and DHEA levels in cord blood, Sapporo, Japan, 2002--2005 (*n* = 185). The LSMs were adjusted for gestational age, maternal age, smoking and caffeine intake during pregnancy, parity, maternal educational level, and the blood sampling period. The LSMs were back transformed from log~10~ to normal values, and the error bars depict the upper and lower 95% CI. Q, quartile.](EHP142.g001){#f1}

Discussion
==========

In this study we addressed the association of PFCs with cord blood glucocorticoid and androgenic hormone levels in a prospective birth cohort. We found a significant negative association of prenatal PFOS levels with cortisol and cortisone levels in cord blood samples. In addition, we found a nonsignificant positive association of prenatal PFOA with cortisol and cortisone levels. We observed a positive association between PFOS and DHEA levels, whereas PFOA was inversely associated with DHEA levels. Our results provide new evidence regarding the association of exposure to low levels of PFCs *in utero* with the concentration of glucocorticoid and androgenic hormones in the next generation.

Median maternal concentrations for PFOS and PFOA in the present study were 5.2 and 1.4 ng/mL, respectively, which are lower than the median values of cohorts conducted in the United States (PFOS: 8.2, PFOA: 2.9 ng/mL) ([@r41]), Denmark (PFOS: 21.5, PFOA: 3.7 ng/mL) ([@r11]), Norway (PFOS: 13, PFOA: 2.2 ng/mL) ([@r40]), and Korea (PFOS: 9.3, PFOA: 2.6 ng/mL) ([@r26]).

Perinatal steroid hormone concentrations and their variabilities play an essential part in ensuring optimal conditions for the start of human life and maintaining homeostasis in the postnatal period. The correlation between steroid hormones in maternal and cord blood samples is poor. Therefore, steroid hormone concentrations of cord blood provide a better indicator of fetal endocrine milieu ([@r45]). Steroid hormones fluctuate during pregnancy and in postnatal life; for example, androgenic hormones gradually increase in maternal blood during pregnancy and are present in high levels at birth in cord blood but rapidly decrease during early infancy ([@r24]). Also, animal and human data suggest that perinatal glucocorticoid levels program the fetal hypothalamic--pituitary--adrenal (HPA) axis affecting its development, resulting in changes in HPA axis function that persist throughout life ([@r18]; [@r48]). Therefore, cord blood glucocorticoid and androgenic hormone levels may be appropriate indicators to predict HPA axis function and health in later life.

The values we obtained for glucocorticoids in cord blood samples in our study are comparable with those in cord blood samples both in and outside of Japan ([@r1]; [@r12]). In our study, glucocorticoid levels did not differ by sex, and the average DHEA level was higher in female infants, which is in line with previous studies ([@r14]). Pregnancy is a transient, but physiologic, period of hypercortisolism, and glucocorticoids are essential for regulating and/or modulating normal physiologic functions in metabolism, growth, neurodevelopment, the immune system, blood pressure maintenance, and fluid and electrolyte homeostasis ([@r4]; [@r37]). Moreover, glucocorticoids have a crucial role in late gestational lung and heart maturation, and insufficient or excess amounts of these hormones have lifelong adverse effects on the cardiovascular system ([@r14]; [@r38]). In addition, cord blood cortisol level is lower in infants with intrauterine growth retardation than in infants with appropriate growth for their gestational age ([@r42]). However some other reports suggest associations between prenatal exposure to synthetic glucocorticoids and reduced birth size ([@r19]). Our findings suggest that dyshomeostasis of glucocorticoids and DHEA at birth are associated with *in utero* PFCs exposure, and this may have adverse effects on the HPA axis and steroid hormone homeostasis in later life. Therefore, *in utero* PFC exposure may be a public health concern, and long-term observation of these effects is warranted.

Fetal serum glucocorticoid levels in humans are related to gestational age ([@r38]). During data analysis, we used gestational age (days) as a confounder in the adjusted model to reduce the possibility of the effect of short gestational age on decreased cortisol and cortisone levels in cord blood. Within our study population, only one infant was premature (gestational age \< 37 weeks). For further examination, we excluded this subject from the data analysis, but this did not change the results, indicating that the results may not be biased by gestational age as a determinant factor of glucocorticoid levels. Some previous studies have suggested that glucocorticoid levels in the cord blood of infants born by vaginal delivery are higher than those in infants born by cesarian section ([@r36]). In our study, all pregnant women had a vaginal delivery at the same hospital, with uncomplicated singleton pregnancies. Therefore, this cannot be a confounder in our study. Our results showed a significant negative association of glucocorticoids in cord blood with maternal age and multiparity, which is consistent with previous studies ([@r9]). Because of the importance of parity on glucocorticoid levels, we stratified the association between PFOS and glucocorticoids by parity (0, ≥ 1) and observed that the association between PFOS and glucocorticoids was stronger in infants whose mothers were nulliparous. For further assessment of the association between PFCs and glucocorticoids, we included the Apgar score (1 min after birth, continuous variable) as an indicator of infant stress at birth into the adjusted model, and the results remained consistent. Moreover, PFOA and PFOS levels were not strongly correlated in this study (Spearman's rho = 0.270), and mutual adjustment did not change the results in any consistent way.

The fetal adrenal gland uses large amounts of progesterone supplied by the placenta for cortisol synthesis ([@r30]). PFOS can inhibit the secretion of progesterone in a concentration-dependent manner in human placental syncytiotrophoblasts ([@r56]). [@r3] reported a negative association between serum PFOS exposure (but not PFOA) and saliva progesterone levels in healthy nulliparous women 25--35 years of age. In addition, we reported that prenatal exposure to PFOS was inversely associated with progesterone levels in cord blood of male and female infants in the same cohort. In contrast, prenatal PFOA levels were positively associated with cord blood progesterone levels in male and female infants ([@r15]). Therefore, this may partly explain the negative association of PFOS but not PFOA with glucocorticoids in the present study. Previously, we reported a negative association between prenatal exposure to PFOS and maternal triglyceride and long-chain polyunsaturated fatty acids (FAs) during pregnancy, including essential FAs and omega 3 and omega 6 FAs in the same cohort ([@r21]), whereas PFOA had a nonsignificant positive association with triglyceride and most FAs. However, we did not measure cholesterol levels in this population, making it difficult to interpret the mechanistic effects of PFCs on steroid hormones through cholesterol metabolism.

The mode of action(s) that explains the correlation between PFC exposure and steroid hormones is not fully understood. However, the most putative targets of PFCs are nuclear receptors including peroxisome proliferator-activated receptor (PPAR)α, PPARγ, estrogen, and androgen receptors ([@r23]; [@r43]; [@r47]). These genes are involved in cholesterol metabolism, lipid transport, and steroid synthesis. Therefore, PFCs may change steroid hormone homeostasis by affecting different genes and mechanisms of action.

PFCs, especially PFOS, inhibit the activity of several enzymes in the pathway of steroidogenesis in human cells, such as 3β-hydroxysteroid dehydrogenase (HSD3B), that convert pregnenolone to progesterone and DHEA to androstenedione ([@r57]). PFOS, and PFOA with weaker potency, inhibits 11β-hydroxysteroid dehydrogenase 2 (11β-HSD2) which converts cortisol to cortisone ([@r55]; [@r58]). Therefore, these modified enzyme activities may disrupt the ratios of cortisol/cortisone, cortisol/DHEA, and C19-steroids (androgenic hormones) and C21-steroids (glucocorticoids). We found that PFOS is associated with a decrease in the cortisol/DHEA ratio and glucocorticoid/androgenic hormone ratio, indicating that PFOS may shift steroidogenesis to androgenic hormones ([Table 5](#t5){ref-type="table"}). Also, PFOS was associated with an increased cortisol/cortisone ratio, which suggests inhibition of 11β-HSD2 enzyme. In contrast, PFOA was associated with these ratios in the opposite direction. In this study, we found that the direction of PFOS and PFOA effects on steroids are different, and further studies are necessary to replicate these findings and clarify the mechanistic effects of these PFCs on steroidogenesis.

In this study, we measured prenatal PFC levels in a prospective birth cohort and have provided new evidence regarding the association between *in utero* PFC exposure levels and cord blood steroid hormones. In addition, we assessed steroid hormone levels using LC-MS/MS, which has a very high sensitivity and specificity compared with immunoassay. However, this study has some limitations. The participation rate in this study was low due to the exclusion of eligible women who decided to participate in the Japanese cord blood bank. In addition, only mother--infant pairs with available prenatal and cord blood samples (*n* = 185) were included in the present study, which may have led to potential selection bias. Mother--infants pairs included in the present analysis, compared with the original cohort, were more often primipara, had longer gestational age, and had a lower percentage of male infants (see Table S5). However, compared with the original cohort, mother--infant pairs in the present data analysis had similar PFCs exposure levels as well as characteristics including maternal age, prepregnancy maternal BMI, socioeconomic status, and smoking rate during pregnancy.

Our group previously reported time trends of 11 types of PFCs between 2003 and 2011 in plasma samples during pregnancy in Hokkaido, Japan. The results indicated that concentrations of PFOS and PFOA were declining, whereas levels of PFCs with longer carbon chains such as PFNA and PFDA were increasing ([@r34]). Additionally, previous laboratory studies suggest greater toxicity of PFCs with longer carbon chains ([@r52]). Therefore, more studies to clarify the effects of PFCs with longer carbon chains on steroid hormone profile are necessary. In addition, some recent studies have suggested that the placenta plays an important role in regulation of 11β-HSD2 enzyme activity and glucocorticoid levels resulting in poor birth weight and neurodevelopment outcomes ([@r29]; [@r48]). The placenta is an important tissue for regulating endogenous hormone synthesis and passage. Examination of placental tissue along with cord blood may be a promising approach for future studies.
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=====================
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Click here for additional data file.
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